Autopsy report · NCT02282111

EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors

“Equality of results between the two groups at interim analysis”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Ran for about 3 years 4 months before it stopped.
• 56 participants enrolled.
• Results were posted on the registry 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Johns Hopkins University

Sponsor type

University, hospital or other

Conditions

Esophageal Subepithelial Lesions

Interventions

22-gauge Procore needle (ProCore, Cook Medical Inc., Winston-Salem, NC); conventional needle-knife sphincterotome (Microknife XL; Boston Scientific Inc, Natick, Mass)

Participants

56

Sites

1

Countries

United States

Trials that died the same way

• Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGT
  “We obtained the final results due to the interim analysis.” (67% match in meaning)
• Do Peanut Shaped Birthing Balls Reduce the Length of Labor in Patients With Epidural Analgesia?
  “During interim analysis, it appeared there were no difference in groups” (66% match in meaning)
• Cardioneuroablation: Comparison of Right Versus Left Atrial Approach in Patients With Reflex Syncope
  “Significant differences between the groups were noted during interim analysis (as scheduled in the protocol) and the study was stopped because the final result was obtained” (63% match in meaning)
• Conversational Hypnosis in Women Undergoing Imaging for Breast Cancer
  “Results not achievable after interim analysis conclusions and recruting difficulty” (58% match in meaning)
• ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients
  “Lack of effect in interim analysis” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.